Identification of dual positive CD19+/CD3+ T cells in a leukapheresis product undergoing CAR transduction: a case report

BACKGROUND: Chimeric antigen receptor (CAR) therapy and hematopoietic stem cell transplantation (HSCT) are therapeutics for relapsed acute lymphocytic leukemia (ALL) that are increasingly being used in tandem. We identified a non-physiologic CD19+/CD3+ T-cell population in the leukapheresis product...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Immunother Cancer
Main Authors: Schultz, Liora, Patel, Shabnum, Davis, Kara Lynn, Ramakrishna, Sneha, Sahaf, Bita, Bhatia, Neehar, Baggott, Christina, Erickson, Courtney, Majzner, Robbie G, Oak, Jean, Bertaina, Alice, Mackall, Crystal, Feldman, Steven
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2020
Teme:
Case Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7490929/
https://ncbi.nlm.nih.gov/pubmed/32929049
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001073
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki